Clinical Trial Update: Overlooked Barrier To Discontinuing Bont-A Therapy

View source ↗

Summary

Completed clinical trial examining barriers to discontinue botulinum toxin type A therapy in patients with post-stroke spastic hemiplegia, highlighting challeng…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Spasticity

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Suleyman Demirel University | Conditions: Post Stroke Spastic Hemiplegia | Status: COMPLETED